Literature DB >> 23427221

Psychiatric disorders in toxoplasma seropositive patients--the CD8 connection.

Rajarshi Bhadra1, Dustin A Cobb, Louis M Weiss, Imtiaz A Khan.   

Abstract

Although the highest numbers of studies linking an infectious agent with schizophrenia has involved the parasite Toxoplasma gondii, the mechanistic underpinnings of this correlation has remained unaddressed. Incidentally, CD8 T cells, which play a pivotal role in mediating long-term immunity to Toxoplasma, are downregulated in schizophrenia patients. Recent studies have demonstrated that CD8 response is also impaired during chronic toxoplasmosis in murine models. In light of these new findings, in this article, we discuss the potential role of CD8 T cells in causing altered mental status in Toxoplasma seropositive schizophrenia patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427221      PMCID: PMC3627775          DOI: 10.1093/schbul/sbt006

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  27 in total

1.  Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism.

Authors:  N D Volkow; J Logan; J S Fowler; G J Wang; R C Gur; C Wong; C Felder; S J Gatley; Y S Ding; R Hitzemann; N Pappas
Journal:  Am J Psychiatry       Date:  2000-01       Impact factor: 18.112

2.  Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.

Authors:  Michal J Besser; Yonatan Ganor; Mia Levite
Journal:  J Neuroimmunol       Date:  2005-09-15       Impact factor: 3.478

3.  Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis.

Authors:  B Saha; A C Mondal; S Basu; P S Dasgupta
Journal:  Int Immunopharmacol       Date:  2001-07       Impact factor: 4.932

4.  Toxoplasma gondii infection in the United States: seroprevalence and risk factors.

Authors:  J L Jones; D Kruszon-Moran; M Wilson; G McQuillan; T Navin; J B McAuley
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

5.  The decrease of CD8-positive lymphocytes in Alzheimer's disease.

Authors:  T Pirttilä; S Mattinen; H Frey
Journal:  J Neurol Sci       Date:  1992-02       Impact factor: 3.181

Review 6.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

7.  Toxoplasma gondii infection and self-directed violence in mothers.

Authors:  Marianne G Pedersen; Preben Bo Mortensen; Bent Norgaard-Pedersen; Teodor T Postolache
Journal:  Arch Gen Psychiatry       Date:  2012-11

8.  Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii.

Authors:  Lorraine Jones-Brando; E Fuller Torrey; Robert Yolken
Journal:  Schizophr Res       Date:  2003-08-01       Impact factor: 4.939

9.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii.

Authors:  R Gazzinelli; Y Xu; S Hieny; A Cheever; A Sher
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

10.  Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus.

Authors:  J P Webster; C F Brunton; D W MacDonald
Journal:  Parasitology       Date:  1994-07       Impact factor: 3.234

View more
  14 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 2.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

3.  Genomics of schizophrenia: time to consider the gut microbiome?

Authors:  T G Dinan; Y E Borre; J F Cryan
Journal:  Mol Psychiatry       Date:  2014-10-07       Impact factor: 15.992

Review 4.  The known and missing links between Toxoplasma gondii and schizophrenia.

Authors:  Hany M Elsheikha; Dietrich Büsselberg; Xing-Quan Zhu
Journal:  Metab Brain Dis       Date:  2016-04-04       Impact factor: 3.584

Review 5.  Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.

Authors:  Monojit Debnath
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-11       Impact factor: 4.147

Review 6.  Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases.

Authors:  J Xiao; R H Yolken
Journal:  Acta Physiol (Oxf)       Date:  2015-01-28       Impact factor: 6.311

7.  Chronic Toxoplasma gondii Infection Induces Anti-N-Methyl-d-Aspartate Receptor Autoantibodies and Associated Behavioral Changes and Neuropathology.

Authors:  Ye Li; Raphael P Viscidi; Geetha Kannan; Ross McFarland; Mikhail V Pletnikov; Emily G Severance; Robert H Yolken; Jianchun Xiao
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Donor CD8+ T cells prevent Toxoplasma gondii de-encystation but fail to rescue the exhausted endogenous CD8+ T cell population.

Authors:  Rajarshi Bhadra; Dustin A Cobb; Imtiaz A Khan
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

9.  Electrophysiological Neuroimaging using sLORETA Comparing 100 Schizophrenia Patients to 48 Patients with Major Depression.

Authors:  Andy R Eugene; Jolanta Masiak
Journal:  Brain (Bacau)       Date:  2014-12

Review 10.  Immune aging, dysmetabolism, and inflammation in neurological diseases.

Authors:  Michela Deleidi; Madeline Jäggle; Graziella Rubino
Journal:  Front Neurosci       Date:  2015-06-03       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.